TScan Therapeutics (TCRX) Announces CEO Transition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. SPY
4. BILL
5. WMT
6. ADI
7. ROST
8. MRK
9. MRNA
10. COTY

Go back to TScan Therapeutics (TCRX) Announces CEO Transition
Dreyfus/Laurel Funds Trust Dreyfus Core Value Fund Class I (NASDAQ: TCRX) Delayed: 0.78 +0.03 (4.00%)
Previous Close $0.75    52 Week High $26.80 
Open $0.75    52 Week Low $23.00 
Day High $0.79    P/E N/A 
Day Low $0.75    EPS $0.00 
Volume 337,142